Patents by Inventor Michael Love
Michael Love has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11900067Abstract: Improved multi-modal machine learning networks integrate computer vision systems with language models. In certain embodiments, a computer vision system analyzes at least one image to generate a computer vision output. The language model generates an output based, at least in part, on a consideration of the computer vision output. The outputs of the language model can be generated by jointly considering textual information learned by the language model and visual content extracted by the computer vision system, thereby significantly improving the accuracy, breadth, and comprehensiveness of the outputs.Type: GrantFiled: September 21, 2023Date of Patent: February 13, 2024Assignee: SURGETECH, LLCInventors: Michael Love, Blake Love, Tiago Soromenho
-
Publication number: 20240023848Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned analyte sensor automatically or on demand upon request from a user.Type: ApplicationFiled: February 17, 2023Publication date: January 25, 2024Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
-
Patent number: 11874127Abstract: This disclosure relates to improved techniques for personalizing vehicle routes and operator sessions using pre-trained machine learning language models. In certain embodiments, a language model is trained on operator interaction data to learn operator route preferences for vehicle operators. These learned operator route preferences can be leveraged to optimize and personalize vehicle routes and operator sessions in various ways. Other embodiments are disclosed herein as well.Type: GrantFiled: March 14, 2023Date of Patent: January 16, 2024Assignee: SURGETECH, LLCInventors: Michael Love, Blake Love, Tiago Soromenho
-
Patent number: 11808594Abstract: This disclosure relates to improved techniques for personalizing vehicle routes and operator sessions using pre-trained machine learning language models. In certain embodiments, a language model is trained on operator interaction data to learn operator route preferences for vehicle operators. These learned operator route preferences can be leveraged to optimize and personalize vehicle routes and operator sessions in various ways. Other embodiments are disclosed herein as well.Type: GrantFiled: April 14, 2023Date of Patent: November 7, 2023Assignee: SURGETECH, LLCInventors: Michael Love, Blake Love, Tiago Soromenho
-
Patent number: 11803710Abstract: Improved multi-modal machine learning networks integrate computer vision systems with language models. In certain embodiments, a computer vision system analyzes at least one image to generate a computer vision output. The language model generates an output based, at least in part, on a consideration of the computer vision output. The outputs of the language model can be generated by jointly considering textual information learned by the language model and visual content extracted by the computer vision system, thereby significantly improving the accuracy, breadth, and comprehensiveness of the outputs.Type: GrantFiled: March 28, 2023Date of Patent: October 31, 2023Assignee: SURGETECH, LLCInventors: Michael Love, Blake Love, Tiago Soromenho
-
Patent number: 11790240Abstract: This disclosure relates to artificial intelligence (AI) and machine learning networks for predicting or determining demand metrics across multiple channels. An analytics platform can receive channel events from multiple channels corresponding to geographic areas, and channel features related to demand conditions in the channels can be extracted from the channel events. During a training phase, the channel features can be accumulated into one or more training datasets for training one or more demand prediction models. The one or more demand prediction models can be trained to predict or determine demand metrics for each of the channels. The demand metrics can indicate or predict demand conditions based on the current conditions in the channels and/or based on future, predicted conditions in the channels. Other embodiments are disclosed herein as well.Type: GrantFiled: February 10, 2023Date of Patent: October 17, 2023Assignee: SURGETECH, LLCInventors: Michael Love, Blake Love, Tiago Soromenho, Alexander Starks, Matthew Paff
-
Publication number: 20230268071Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: February 28, 2023Publication date: August 24, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Patent number: 11730429Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: GrantFiled: January 20, 2022Date of Patent: August 22, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman, Erich Yen
-
Publication number: 20230248272Abstract: A system for measurement of an analyte level including an analyte sensor having an in vivo portion in contact with the interstitial fluid of a user and an ex vivo portion. The sensor further includes at least one working electrode and a reference electrode located on the in vivo portion, and a first substrate. The at least one working electrode and reference electrode sense signals associated with a measured analyte level in the interstitial fluid of a user. Further, the ex vivo portion includes a plurality of electronic components mounted thereon, and at least one of the electronic components are configured to receive the generated signals associated with the measured analyte level. The electronic components are mounted to the ex vivo portion using photonic soldering.Type: ApplicationFiled: February 6, 2023Publication date: August 10, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Peter M. Voit, Jean-Pierre Cole, Thomas Meyer, Michael Love
-
Publication number: 20230238131Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: April 3, 2023Publication date: July 27, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Patent number: 11665076Abstract: This disclosure relates to decentralized computing networks, architectures and techniques for collecting, analyzing, and processing data over multiple channels. A decentralized computing network comprises a plurality of computing nodes, each of which is dedicated to analyzing and processing events for a particular channel corresponding to a geographic region. Each node of the decentralized computing network can operate independently to process channel analysis data for a corresponding channel. The decentralized configuration of the nodes enables efficient processing of data collected over large geographic areas, increases the reliability of the system, and facilitates easy scaling of the system. Other embodiments are disclosed herein as well.Type: GrantFiled: December 2, 2022Date of Patent: May 30, 2023Assignee: SURGETECH, LLCInventors: Michael Love, Blake Love, Tiago Soromenho
-
Publication number: 20230157643Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.Type: ApplicationFiled: January 6, 2023Publication date: May 25, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Gary Alan Hayter, Nathan Christopher Crouther, Michael Love, Erwin Satrya Budiman, Daniel Milfred Bernstein
-
Patent number: 11553883Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.Type: GrantFiled: July 8, 2016Date of Patent: January 17, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Gary Alan Hayter, Nathan Christopher Crouther, Michael Love, Erwin Satrya Budiman, Daniel Milfred Bernstein
-
Publication number: 20220401041Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: August 18, 2022Publication date: December 22, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20220359074Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: July 14, 2022Publication date: November 10, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20220240821Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: April 14, 2022Publication date: August 4, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20220233110Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: April 14, 2022Publication date: July 28, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20220233111Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: April 14, 2022Publication date: July 28, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Patent number: D957642Type: GrantFiled: April 1, 2021Date of Patent: July 12, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
-
Patent number: D957643Type: GrantFiled: April 1, 2021Date of Patent: July 12, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee